The first compulsory license by the Indian government: boon or Bane?
April 2012:
This is indeed good news for the burgeoning middle class who could now afford the drug for their treatment. However there are many questions that are unanswered. It’s true that reducing the price by 97% will definitely help many but it might be more interesting if government adopts the model used by developed economies and provides health coverage to the entire population in the country. Currently 60% of the population is deprived of such health coverage. So, even with so much significant reduction in the price of the drug, there still might be barriers to access it.
Leave a Comments